Transient effusive-constrictive pericarditis due to chemotherapy
- PMID: 10198745
- PMCID: PMC6655903
- DOI: 10.1002/clc.4960220414
Transient effusive-constrictive pericarditis due to chemotherapy
Abstract
Commonly used chemotherapeutic agents, specifically cytarabine and daunorubicin, can cause effusive-constrictive pericarditis. We describe a case of transient effusive-constrictive pericarditis in a patient with acute myelogenous leukemia. This is the first case report of a patient with transient effusive-constrictive pericarditis due to chemotherapy.
References
-
- Soler‐Soler J: Pericardial Disease. New Insights and Old Dilemmas, p. 37 Dordrecht: Kluwer Academic Publishers, 1990.
-
- Allen A: The cardiotoxicity of chemotherapeutic drugs. Semin Oncol 1992; 19: 529–542 - PubMed
-
- Ahmed M, Slayton RE: Report on drug‐induced pericarditis. Cancer Treat Rep 1980; 64: 353–355 - PubMed
-
- Reykdal S, Kouides P: Cytarabine‐induced pericarditis: A case report and review of the literature of the cardio‐pulmonary complications of cytarabine therapy. Leukemia Res 1995; 19: 2: 141–144 - PubMed
-
- Vaickus L, Letendre L: Pericarditis induced by high dose cytarabine therapy. Arch Intern Med 1984; 144: 1868–1869 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
